Trials / Completed
CompletedNCT01297257
DELIVER Study: DELiverability of the Resolute Integrity Stent in All-Comer Vessels and Cross-OvER Stenting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7,845 (actual)
- Sponsor
- Medtronic Vascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the DELIVER Study is to assess the deliverability of the Resolute Integrity Stent as primary stent or as a secondary cross-over stent following delivery failure of another stent type in real world patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Stent implantation | Single arm, open label stent implantation |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2012-10-01
- Completion
- 2013-04-01
- First posted
- 2011-02-16
- Last updated
- 2014-03-06
- Results posted
- 2014-03-06
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01297257. Inclusion in this directory is not an endorsement.